This review discusses the evidence for use of alginate/antacid as a monotherapy, co-prescribed with proton pump inhibitors (PPIs), as a rescue therapy in those stopping PPIs, as well as use in pregnant and breast-feeding women.
It also provides commentary and guidance from Associate Professor Jonathan Segal a gastroenterologist at the Royal Melbourne Hospital and the Peter MacCallum Cancer Centre.
Please login below to download this issue (PDF)